Vinayak Bhat

556 total citations
17 papers, 435 citations indexed

About

Vinayak Bhat is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Vinayak Bhat has authored 17 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Vinayak Bhat's work include Coronary Interventions and Diagnostics (10 papers), Cardiac Imaging and Diagnostics (7 papers) and Cardiac Valve Diseases and Treatments (4 papers). Vinayak Bhat is often cited by papers focused on Coronary Interventions and Diagnostics (10 papers), Cardiac Imaging and Diagnostics (7 papers) and Cardiac Valve Diseases and Treatments (4 papers). Vinayak Bhat collaborates with scholars based in United States, Brazil and Belgium. Vinayak Bhat's co-authors include W.M. Reichert, George A. Truskey, John Yan, Ricardo A. Costa, Stefan Verheye, Alexandre Abizaid, Sara Toyloy, J. Ribamar Costa, Lynn Morrison and Daniel Chamié and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Biomedical Materials Research and Biotechnology Progress.

In The Last Decade

Vinayak Bhat

16 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinayak Bhat United States 9 312 168 143 111 68 17 435
D. Whelan Netherlands 9 404 1.3× 223 1.3× 179 1.3× 65 0.6× 40 0.6× 9 544
Kaname Takizawa Japan 9 331 1.1× 165 1.0× 127 0.9× 120 1.1× 50 0.7× 25 514
Jeffrey T. Krawiec United States 6 226 0.7× 135 0.8× 222 1.6× 161 1.5× 181 2.7× 6 582
Marc Vorpahl Germany 11 583 1.9× 395 2.4× 263 1.8× 36 0.3× 58 0.9× 28 712
Boris Behnisch Germany 7 227 0.7× 134 0.8× 99 0.7× 40 0.4× 20 0.3× 13 358
Ulrich Stock Germany 11 455 1.5× 177 1.1× 68 0.5× 351 3.2× 207 3.0× 26 692
Rolf Rüdiger Meliß Germany 9 346 1.1× 143 0.9× 52 0.4× 256 2.3× 77 1.1× 17 509
Peter Benedikt Austria 6 280 0.9× 134 0.8× 65 0.5× 250 2.3× 189 2.8× 13 471
Joan Ellinger United States 14 226 0.7× 28 0.2× 92 0.6× 224 2.0× 61 0.9× 26 408
Po-Feng Lee United States 11 150 0.5× 172 1.0× 168 1.2× 112 1.0× 139 2.0× 19 488

Countries citing papers authored by Vinayak Bhat

Since Specialization
Citations

This map shows the geographic impact of Vinayak Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinayak Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinayak Bhat more than expected).

Fields of papers citing papers by Vinayak Bhat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinayak Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinayak Bhat. The network helps show where Vinayak Bhat may publish in the future.

Co-authorship network of co-authors of Vinayak Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of Vinayak Bhat. A scholar is included among the top collaborators of Vinayak Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinayak Bhat. Vinayak Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Verheye, Stefan, Marie‐Claude Morice, Carlo Zivelonghi, et al.. (2022). 24-Month Clinical Follow-Up and Mechanistic Insights From Intravascular Imaging Following Coronary Implantation of the Novel DynamX Bioadaptor Platform. Cardiovascular revascularization medicine. 46. 106–112. 7 indexed citations
2.
3.
Shibbani, Kamel, Marie‐France Poulin, Karim Diab, et al.. (2020). Preclinical comparative assessment of a dedicated pediatric poly‐L‐lactic‐acid‐based bioresorbable scaffold with a low‐profile bare metal stent. Catheterization and Cardiovascular Interventions. 96(4). 878–888. 9 indexed citations
4.
Abizaid, Alexandre, Mathias Vrolix, J. Ribamar Costa, et al.. (2017). TCT-330 Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results. Journal of the American College of Cardiology. 70(18). B135–B136. 2 indexed citations
5.
Verheye, Stefan, Michael Mæng, Carsten Skurk, et al.. (2017). TCT-16 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 5-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 70(18). B7–B8. 1 indexed citations
6.
Abizaid, Alexandre, Ricardo A. Costa, Joachim Schöfer, et al.. (2016). Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. JACC: Cardiovascular Interventions. 9(6). 565–574. 88 indexed citations
7.
Verheye, Stefan, Mark Webster, Jim Stewart, et al.. (2013). CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results. JACC: Cardiovascular Interventions. 6(2). S2–S2. 1 indexed citations
8.
Verheye, Stefan, John A. Ormiston, James T. Stewart, et al.. (2013). A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation. JACC: Cardiovascular Interventions. 7(1). 89–99. 129 indexed citations
9.
Verheye, Stefan, Mark Webster, James T. Stewart, et al.. (2012). TCT-563 Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results. Journal of the American College of Cardiology. 60(17). B163–B163. 8 indexed citations
10.
Yan, John & Vinayak Bhat. (2009). Elixir Medical’s bioresorbable drug eluting stent (BDES) programme: an overview. EuroIntervention. 5(F). F80–F82. 11 indexed citations
11.
Abizaid, Alexandre, Fausto Feres, Ricardo A. Costa, et al.. (2008). EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention. 4(1). 53–58. 27 indexed citations
12.
Bhat, Vinayak, George A. Truskey, & W.M. Reichert. (1998). Fibronectin and avidin-biotin as a heterogeneous ligand system for enhanced endothelial cell adhesion. Journal of Biomedical Materials Research. 41(3). 377–385. 45 indexed citations
13.
Bhat, Vinayak, George A. Truskey, & W.M. Reichert. (1998). Using avidin-mediated binding to enhance initial endothelial cell attachment and spreading. Journal of Biomedical Materials Research. 40(1). 57–65. 37 indexed citations
14.
Bhat, Vinayak, et al.. (1998). Improving endothelial cell adhesion to vascular graft surfaces: Clinical need and strategies. Journal of Biomaterials Science Polymer Edition. 9(11). 1117–1135. 57 indexed citations
15.
Bhat, Vinayak, George A. Truskey, & W.M. Reichert. (1998). Using avidin‐mediated binding to enhance initial endothelial cell attachment and spreading. Journal of Biomedical Materials Research. 40(1). 57–65. 1 indexed citations
16.
Bhat, Vinayak, George A. Truskey, & W.M. Reichert. (1998). Fibronectin and avidin–biotin as a heterogeneous ligand system for enhanced endothelial cell adhesion. Journal of Biomedical Materials Research. 41(3). 377–385. 2 indexed citations
17.
Bhat, Vinayak, et al.. (1995). Fluctuating Shear Stress Effects on Stress Fiber Architecture and Energy Metabolism of Cultured Renal Cells. Biotechnology Progress. 11(5). 596–600. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Whelan Breakdown of academic impact, for papers by Kaname Takizawa Breakdown of academic impact, for papers by Jeffrey T. Krawiec Breakdown of academic impact, for papers by Marc Vorpahl Breakdown of academic impact, for papers by Boris Behnisch Breakdown of academic impact, for papers by Ulrich Stock Breakdown of academic impact, for papers by Rolf Rüdiger Meliß Breakdown of academic impact, for papers by Peter Benedikt Breakdown of academic impact, for papers by Joan Ellinger Breakdown of academic impact, for papers by Po-Feng Lee
Rankless by CCL
2026